Metrnl/Meteorin-like/IL-41, a novel regulator of bone metabolism and disease activity in ankylosing spondylitis: based on multi-omics analysis.

Front Immunol · 2025 · PMC12325251 · PMID 40771822

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

On Day 28, large patches of orange-red precipitates were visible to the naked eye within the plates, with a slight trend towards a reduced area of precipitates in the Metrnl-treated groups compared to the control, but the differences were minor. 3.5.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.